Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
Open Access
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (16), 2474-2486
- https://doi.org/10.3748/wjg.14.2474
Abstract
Estimates of people suffering from overweight (one billion) and obesity (300 million) are increasing. The accumulation of triglycerides in the liver, in the absence of excess alcohol intake, has been described in the early sixties. It was not until 1980, however, that Ludwig et al named this condition nonalcoholic steatohepatitis (NASH). Subsequently, nonalcoholic fatty liver disease (NAFLD) has been used as a general name for conditions ranging from simple steatosis through steatohepatitis to end-stage liver disease (cirrhosis). Many studies have demonstrated the significant correlation with obesity and insulin resistance. Other studies have revealed a significant correlation between hepatic steatosis, cardiovascular disease and increased intima-media thickness. WHO estimated that at least two million patients will develop cirrhosis due to hepatic steatosis in the years to come. Longitudinal cohort studies have demonstrated that those patients with cirrhosis have a similar risk to develop hepatocellular carcinoma as those with other causes of cirrhosis. Taken all together, NAFLD has become the third most important indication for liver transplantation. Therefore, training programmes in internal medicine, gastroenterology and hepatology should stress the importance of diagnosing this entity and treat properly those at risk for developing complications of portal hypertension and concomittant cardiovascular disease. This review will focus on the clinical characteristics, pathophysiology, imaging techniques and the readily available therapeutic options.Keywords
This publication has 142 references indexed in Scilit:
- Pathophysiology of insulin resistanceBest Practice & Research Clinical Endocrinology & Metabolism, 2006
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat‐selective MRI and volume‐localized 1H‐MR spectroscopyMagnetic Resonance in Medicine, 2006
- Computed Tomography in Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006
- Hepatocellular carcinoma with nonalcoholic steatohepatitisThe Esophagus, 2004
- Body mass index as a predictor of hepatic steatosis in living liver donorsLiver Transplantation, 2001
- Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot studyThe Journal of Pediatrics, 2000
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996